Radicle Science Launches Study to Determine Effectiveness of CBD Products

Featuring Parker, Colorado-based CBD company Maven Hemp

The 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. brands, including Maven Hemp.

Radicle Science, a transformative healthtech B-corp validating natural products for the first time, announces the launch of the Radicle ACES (Advancing CBD Education and Science) study.

Using a virtual, direct to consumer (D2C) approach, Radicle ACES is the largest and most comprehensive randomized controlled trial (RCT) of its kind, collecting data on thirteen mission-driven U.S. CBD brands, featuring Maven Hemp alongside ALTWELL, Charlotte’s Web, Columbia Care, Healer, Lord Jones, MD FARMA, Peels (a citrus-derived brand), Prospect Farms, PURAURA Naturals from Enhanced Botanicals, Rae Wellness, Trokie, and Verséa Wellness.

“We believe in the importance of having access to verified data that supports the ways our company makes a positive impact. Participating in the Radicle ACES study allows us to align with Radicle, a B-Corp that shares our values, while building trust and confidence as we work to distribute our products to doctors and patients across The Americas and beyond. We’re also in the process of B-Corp certification, and are making progress towards our impact goals every day. We’re proud to align with mission-driven partners, including Radicle Science and the other 12 brands in the Radicle ACES study.” – Zev Barnett, Founder and CEO of Maven Hemp

Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from 3,000 study participants. During the four-week study, participants will use the Radicle Science platform to track consumption and effectiveness of orally ingested CBD products on well-being, quality of life, pain, sleep disturbance, and anxiety.

Radicle ACES will use validated, standardized health indices to gather health outcome data from a diverse population across a variety of ethnicities, age groups, geographies, behavioral habits, and pre-existing health conditions.

“We’re applying science to understand the effectiveness of CBD products used by tens of millions of Americans every day,” said Jeff Chen, MD/MBA, Co-founder and CEO of Radicle Science.

Academic collaborators include Miroslav Backonja, MD (Clinical Professor, University of
Washington), Chris Colwell, PhD (Professor, UCLA), Derek Loewy, PhD (Director of Behavioral Sleep Medicine at Scripps Clinic Sleep Center), Ethan Russo, MD (Founder and CEO of CReDO Science), Kate Taylor, PhD (Associate Professor, UCLA), Jill Waalen, MD/MPH (Co-Director of Biostatistics at Scripps Research), and more.

The Real World Evidence (RWE) collected will inform scientific understanding on dosing, usage patterns, user characteristics, effectiveness across conditions, and predictors and modifiers of treatment response.

“The Radicle ACES study aims to answer lingering questions as to who should take cannabidiol, how much and for what conditions, as well as differing dosage patterns,” said Ethan Russo, MD, Scientific Expert for Radicle Science, and Founder and CEO of CReDO Science. “CBD is much more subtle in its effects and quite benign compared to THC. Patients are unclear on what product to choose and healthcare providers don’t yet have the data to counsel on proper dosage.”

For Maven Hemp, sharing data and answers from the Radicle ACES study will solidify the company’s ability to create positive impact across the local Colorado hemp production and consumption ecosystem. Alongside the company’s physician partners across the globe, as a custom product manufacturer, Maven Hemp aims to support the realization of improved patient outcomes.

Anonymized aggregate results will be released in October 2021. For more background on Radicle ACES methodology and additional insights from collaborators and experts involved in the study, see these Radicle Resources articles.

Follow Maven Hemp on LinkedIn and Instagram to stay updated on the Radicle ACES study as well as new product offerings. Visit the Maven Hemp website to browse through current products and engage with the company’s efforts to realize positive economic, social and environmental impact locally and internationally.